Differential Gene Induction of Human β-Defensins (hBD-1, -2, -3, and -4) in Keratinocytes Is Inhibited by Retinoic Acid  by Harder, Jürgen et al.
Differential Gene Induction of Human b-Defensins (hBD-1, -2, -3,
and -4) in Keratinocytes Is Inhibited by Retinoic Acid
Ju¨rgen Harder,1 Ulf Meyer-Hoffert,w1 Kai Wehkamp, Lars Schwichtenberg, and Jens-Michael Schro¨der
Clinical Research Unit, Department of Dermatology, University Hospital Schleswig-Holstein, Campus Kiel, Germany; wMicrobiology and Tumor Biology Center
and Smittskyddsinstitutet, Karolinska Institutet, Stockholm, Sweden
Human skin is able to mount a fast response against invading harmful bacteria through the rapid production of
inducible peptide antibiotics such as the human b-defensins (hBD). To gain more insight into the role and regu-
lation of inducible b-defensins in the innate immunity of human skin, we investigated whether gene induction of
the human b-defensins hBD-1, -2, -3, and -4 in keratinocytes is regulated in a similar manner. Therefore, we per-
formed a comparative study of gene expression of these four hBD in primary cultured keratinocytes using real-time
PCR. A basal mRNA expression was observed for all four hBD in primary keratinocytes, which strongly increased
for hBD-2, -3, and -4 during Ca2þ -induced differentiation of the keratinocytes. This effect was completely abolished
when the keratinocytes were pre-treated with all-trans-retinoic acid (RA). Furthermore, the differential induction of
hBD-2, -3, and -4 gene expression in keratinocytes by proinﬂammatory cytokines, phorbol-myristate-acetate (PMA),
and bacteria was inhibited by more than 90% when the keratinocytes were pre-incubated with RA. Inhibition of IL-
1b-mediated hBD-2 induction through RA was further conﬁrmed by gene reporter assays and western-blot analysis.
We conclude that RA is a potent inhibitor of b-defensin induction in keratinocytes and might downregulate the
inducible innate chemical defense system of human skin.
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Despite constant exposure of human skin to a wide variety
of potential harmful microorganisms, skin infections are
rather rare and usually locally limited. The basis of this nat-
ural resistance is not fully understood, but one reason might
be the epithelial production of antimicrobial proteins.
Previous studies have shown that the epithelia of plants,
invertebrates, and vertebrates have the capacity to produce
a set of different antimicrobial proteins, which are believed
to play a key role in epithelial innate immunity (reviewed by
Boman, 1998). These endogenous antimicrobial peptides
are highly effective at killing a broad spectrum of micro-
organisms.
Lysozyme was the first antimicrobial protein shown to be
expressed in human skin (Papini et al, 1982). The increasing
number of recent reports demonstrating the expression of
various antimicrobial peptides in human skin reflects the
significance of antimicrobial proteins in the cutaneous in-
nate chemical defense system: A member of the catheli-
cidin-family termed LL-37, the serine protease inhibitor
antileukoprotease (ALP), adrenomedullin, a novel anionic
peptide called dermcidin, the ribonuclease RNase 7, neu-
trophil gelatinase-associated lipocalin (NGAL), and three
members of the b-defensin family have been reported to
contribute to human skin defense.
The human cathelicidin LL-37 is a proteolytically proc-
essed 37 amino acids containing antimicrobial peptide that
is expressed in inflamed skin but not in healthy skin (Frohm
et al, 1997). The relevance of cathelicidins in cutaneous host
defense has been demonstrated in a mouse model. Mice
deficient in the expression of the cathelicidin CRAMP (the
mouse homolog to the human LL-37) were more suscep-
tible to skin infections caused by group A Streptococcus
(GAS) and GAS mutants resistant to CRAMP produced
more severe skin infections in normal mice (Nizet et al,
2001).
Adrenomedullin, a multifunctional peptide, is expressed
by many epithelia including skin and exhibits antibacterial
activity (Martinez et al, 1997).
The human serine protease inhibitor ALP was isolated
from human callus and detected in supernatants of cultured
human primary keratinocytes. In addition to its antiprotease
activity ALP exhibits high antimicrobial activity against a
broad range of microorganisms indicating that ALP con-
tributes to the high resistance of the epidermis against in-
fections and proteolysis (Wiedow et al, 1998).
Dermcidin is a novel anionic antimicrobial peptide pro-
duced exclusively by human sweat glands (Schittek et al,
2001). This proteolytically processed antimicrobial peptide
is secreted into the sweat and its antimicrobial activity is not
affected by the low pH-value and high salt concentrations of
human sweat.
Keratinocytes also produce RNase 7, a member of the
RNase A superfamily, containing ribonuclease as well as1Both authors contributed equally to this manuscript.
Abbreviations: GAPDH, glyceraldehyde-3-phosphate dehydro-
genase; hBD, human b-defensins; PBS, phosphate-buffered
saline; PMA, phorbol 12-myristate 13-acetate; RA, retinoic acid
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broad-spectrum antimicrobial activity (Harder and Schroe-
der, 2002).
The NGAL, a member of the lipocalin family of binding
proteins, exhibits bacteriostatic activity through binding to
bacterial ferric siderophores. Expression of NGAL in human
keratinocytes is upregulated by IL-1b, IGF-I, and TGF-a
(Sorensen et al, 2003).
One major class of epithelial antimicrobial peptides com-
prises the b-defensins, small (4–5 kDa) cationic peptides
containing high antimicrobial activity against a broad spec-
trum of microorganisms. Human b-defensin-2 (hBD-2) was
originally isolated from the scales of psoriatic skin (Harder et
al, 1997). The expression of hBD-2 in keratinocytes is in-
duced by proinflammatory cytokines (i.e., TNF-a, IL-1b) and
bacteria (Harder et al, 1997; Krisanaprakornkit et al, 2000;
Liu et al, 2002) and increased gene expression could be
detected in inflamed skin (Liu et al, 1998; Schmid et al,
2001). The decreased expression of hBD-2 and LL-37 in
skin lesions of patients with atopic dermatitis suggests that
a deficiency in the expression of antimicrobial peptides may
account for the high occurrence of skin infection in patients
with atopic dermatitis (Ong et al, 2002). The capacity of
hBD-2 to kill bacteria in vivo has been demonstrated in a
mouse gene therapy study with hBD-2-transfected tumor
cells. In this study, hBD-2-bearing tumors were associated
with fewer viable bacteria than controls following bacterial
infection (Huang et al, 2002).
The first discovered human b-defensin, hBD-1, was in-
itially isolated from hemofiltrates (Bensch et al, 1995) and
later found in urine (Valore et al, 1998). In contrast to the
inducible b-defensin hBD-2, only constitutive hBD-1 mRNA
expression was detected in a number of epithelial tissues
(Zhao et al, 1996) including human skin (Fulton et al, 1997).
Immunohistochemistry and in situ hybridization localized
hBD-1 and -2 to the outer layer of the skin supporting the
hypothesis that these b-defensins could participate in a
cutaneous antimicrobial defense system (Fulton et al, 1997;
Ali et al, 2001).
hBD-1 and -2 exhibit antimicrobial activity predominantly
against Gram-negative bacteria, but only low activity
against Gram-positive bacteria. The analysis of human skin
extracts for the presence of Gram-positive bacteria killing
peptides led to the discovery of a novel member of the hBD
family, termed human b-defensin-3 (hBD-3) (Harder et al,
2001). hBD-3 exhibits a broad spectrum of antimicrobial
activity against Gram-negative and Gram-positive bacteria
including multiresistant bacteria and its expression in ker-
atinocytes is induced by bacteria.
Recently, the fourth member of the hBD family, hBD-4,
was discovered by screening the human genome database
(Garcia et al, 2001). Synthetic hBD-4 revealed antimicrobial
activity at micromolar concentrations against Pseudomonas
aeruginosa and Staphylococcus carnosus and hBD-4 gene
expression was upregulated by bacteria in respiratory epi-
thelial cells (Garcia et al, 2001). These data suggest a role of
hBD-4 in the innate epithelial defense system against bac-
teria. So far, nothing is known about the expression of hBD-
4 in human skin. Therefore, we were interested to study if
human keratinocytes are capable of expressing hBD-4 and
whether its expression is induced by the same stimuli as
described for the other members of the b-defensin family.
Furthermore, we investigated whether the level of keratino-
cyte differentiation affects b-defensin gene expression
and whether retinoic acid (RA), a well-known modulator
of keratinocyte differentiation, influences b-defensin gene
expression.
Herein we demonstrate the first comparative study of
the four human b-defensins hBD-1, -2, -3, and -4 in primary
keratinocytes.
Results
hBD-4 mRNA is inducibly expressed in human primary
keratinocytes In this study, we detected a low hBD-4
mRNA expression in unstimulated primary keratinocytes.
Gene expression of hBD-4 in keratinocytes was upregulat-
ed by Ca2þ , TNF-a, IL-1b, phorbol 12-myristate 13-acetate
(PMA), and P. aeruginosa (Fig 1D and 2D).
Ca2þ -induced hBD-1, -2, -3, and -4 gene expression in
human primary keratinocytes Gene expression of hBD-4
and all other tested b-defensins was upregulated by high
Ca2þ (1.7 mM) concentrations (Fig 1A–D). Treatment of the
cells with 1.7 mM Ca2þ led to differentiation of the kera-
tinocytes, which was verified by the upregulation of gene
expression of the differentiation marker Involucrin (Fig 1E).
Treatment of the keratinocytes for 6 d with 1.7 mM Ca2þ
resulted in a 200-fold induction of hBD-2 gene expression,
in a 350-fold induction of hBD-3 gene expression (Fig 1B
and C) and in an 80-fold upregulation of hBD-4 gene ex-
pression (Fig 1D). In contrast, gene expression of hBD-1
was only induced 15-fold following Ca2þ treatment of the
keratinocytes (Fig 1A).
RA inhibits Ca2þ -induced upregulation of hBD-2, -3, and
-4 Since RA modulate keratinocyte differentiation in vitro
(Regnier and Darmon, 1989; Nagpal et al, 1996), we specu-
lated that they could affect the differentiation-associated
b-defensin induction. We therefore investigated whether
Ca2þ -induced b-defensin gene expression was affected by
simultaneous treatment of the keratinocytes with all-trans-
RA. Ca2þ -induced differentiation of the keratinocytes was
inhibited by the addition of 107 M all-trans-RA as shown by
the inhibition of gene induction of the differentiation marker
Involucrin (Fig 1E). Furthermore, the addition of 107 M all-
trans-RA to the Ca2þ -treated keratinocytes completely in-
hibited the Ca2þ -induced upregulation of hBD-2, -3, and -4
(Fig 1B–D). In contrast, the low gene induction of hBD-1 by
Ca2þ was not blocked by RA (Fig 1A).
TNF-a, IL-1b, INF-c, PMA, and P. aeruginosa differential-
ly induce hBD-2, -3, and -4 gene expression in primary
human keratinocytes Gene expression of hBD-1 in pri-
mary keratinocytes was not notably affected by physiologic
stimuli like TNF-a, IL-1b, INF-g, PMA, and P. aeruginosa
(Fig 2A). Unlike hBD-1, gene expression of hBD-2, -3, and
-4 was strongly upregulated by TNF-a, IL-1b, INF-g, PMA, and
P. aeruginosa (Fig 2B–D). P. aeruginosa and PMA are es-
pecially strong inducers of hBD-2, -3, and -4 gene expres-
sion (Fig 2B–D). PMA strongly induced hBD-3 and -4 gene
expression in keratinocytes resulting in a more than 1000-
fold mRNA induction (Fig 2C and D). Whereas INF-g had no
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influence on hBD-2 and -4 induction (Fig 2B and D), it ef-
fectively induced hBD-3 gene expression (Fig 2C).
RA inhibits TNF-a-, IL-1b-, INF-c-, PMA-, and P. aerugi-
nosa-mediated induction of hBD-2, -3, and -4 expres-
sion Treatment of keratinocytes with 107 M all-trans-RA
downregulated the TNF-a-, IL-1b-, INF-g-, PMA-, and P.
aeruginosa-mediated induction of hBD-2, -3, and -4 gene
expression. Pre-incubation of the keratinocytes with 107 M
all-trans-RA for 24 h inhibited hBD-2, -3, and -4 gene in-
duction by more than 90% (Fig 2B–D). A dose–response
analysis of the effect of all-trans-RA on hBD-2 gene ex-
pression induced by IL-1b revealed a half maximum inhibi-
tion at a concentration of 1010 M all-trans-RA (Fig 3).
To determine whether the observed effect of all-trans-RA
seen on the gene expression level correlates with protein
expression, we used a luciferase gene reporter assay and
western-blot analyses. As shown in Fig 4, IL-1b causes a
strong activation of the hBD-2 promoter in primary keratin-
ocytes leading to increased luciferase protein expression.
In concordance to the real-time PCR data, all-trans-RA
strongly suppresses the IL-1b-mediated hBD-2 promoter
activation (Fig 4). In addition, western-blot analysis revealed
that the induction of hBD-2 peptide by IL-1b in primary
keratinocytes is also strongly suppressed by all-trans-RA
(Fig 5).
Discussion
This is the first report demonstrating inducible gene expres-
sion of hBD-4 in human keratinocytes. Further investigations
need to be performed to elucidate the expression levels of
hBD-4 peptide in skin and the role of hBD-4 in the chemical
skin defense system.
The finding that the four b-defensins hBD-1, -2, -3, and
-4 are expressed in relation to the state of differentiation sup-
plements two recent reports demonstrating the regulation
Figure1
Ca2þ induces b-defensin gene expression in human primary
keratinocytes. Primary keratinocytes were incubated for the in-
dicated time period with 1.7 mM Ca2þ in the presence (dark
square) or absence (open diamond) of 107 M all-trans-retinoic
acid. Shown are the relative hBD-1, -2, -3, and -4 transcript lev-
els (analyzed by real-time RT-PCR) normalized to GAPDH tran-
script levels. The data represent the mean  SD of triplicate
samples.
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of hBD-1 and -2 expression by the state of differenti-
ation (Frye et al, 2001; Liu et al, 2002). This may explain why
hBD-1 and -2 peptides show a stronger expression in more
differentiated terminal layers of human skin (i.e., stratum
corneum) and are expressed only at low levels in the un-
differentiated basal layers (Ali et al, 2001). The increased
expression of hBD-1, -2, -3, and -4 in differentiated kera-
tinocytes suggests that the highest quantities of all four b-
defensins are produced in the more differentiated terminal
skin layers, thus providing a first line defense system to
invading microbes. In concordance with this data, Liu et al
(2002) have reported that in an organotypic epidermal cul-
ture increasing concentrations of hBD-2 peptide were de-
tected in the more differentiated suprabasal layers and that
calculated concentrations of hBD-2 in IL-1a-induced epi-
dermal cultures reached concentrations within the anti-
microbial range of hBD-2 (3.5–16 mM). It has recently been
reported that hBD-2 gene expression in the keratino-
cyte cell line HaCaT is not upregulated by increased Ca2þ
concentrations (Abiko et al, 2003). Since these data are
in contrast to our data obtained from primary keratino-
cytes, it appears that HaCaT keratinocytes and primary
keratinocytes differ in relation to the regulation of hBD-2
gene expression.
In contrast to hBD-1, gene expression of hBD-2, -3, and
-4 was strongly upregulated by TNF-a, IL-1b, INF-g, PMA,
and P. aeruginosa. This is in concordance with published
reports demonstrating that hBD-1 is the only hBD whose
Figure 2
Retinoic acid (RA) inhibits induction of b-defensin gene expression in human primary keratinocytes. Primary keratinocytes were stimulated
with 10 ng per mL of the indicated cytokines, 50 ng per mL PMA or 107 per mL heat-inactivated Pseudomonas aeruginosa (P.a.) for 16 h.
Stimulations were performed either without addition of 107 M all-trans-RA (dark column) or with simultaneous addition of 107 M all-trans-RA (mid-
column) or with simultaneous addition of 107 M all-trans-RA and an additional pre-incubation for 24 h with 107 M all-trans-RA (light column). Bars
represent the relative hBD-1, -2, -3, and -4 transcript levels (analyzed by real-time RT-PCR, n.d.¼ not detectable) normalized to GAPDH transcript
levels. The data represent the mean  SD of triplicate samples.
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gene expression is not induced by inflammatory stimuli
(Zhao et al, 1996). Recent reports together with our data
indicate that different cytokines selectively induce a specific
expression pattern of b-defensins in human primary kera-
tinocytes. Using northern-blot technique and a panel of dif-
ferent cytokines (IGF-I, TGF-a, TGF-b, bFGF, IL-1b, IL-6,
TNF-a) to stimulate primary keratinocytes, Sorensen et al
(2003) detected hBD-2 mRNA expression in primary kera-
tinocytes only upon stimulation with IL-1b and hBD-3 mRNA
expression only upon stimulation with TGF-a. Our results
confirmed IL-1b as a potent inducer of hBD-2 expression
and also demonstrate that TNF-a has the capacity to induce
hBD-2 gene expression in primary keratinocytes, a finding
also reported by Nomura et al (2003). Furthermore, our data
identified INF-g as a selective inducer of hBD-3 expression
in primary keratinocyes thus confirming a previous study
demonstrating that IFN-g effectively induces hBD-3 gene
expression in primary keratinocytes (Nomura et al, 2003).
PMA was found to be the strongest inducer of hBD-3 and
-4 gene expression in human primary keratinocytes. In this
context, it is remarkable that Garcia et al (2001) observed no
induction of hBD-3 gene expression in HaCaT keratinocytes
upon PMA (10 ng per mL) treatment. This could indicate that
hBD-3 gene expression in HaCaT keratinocytes and primary
keratinocytes is regulated, at least in part, by a different
mechanism. We used a 5-fold higher PMA concentration,
however, to stimulate the primary keratinocytes offering an-
other explanation for the differences of hBD-3 gene ex-
pression in PMA-treated HaCaT and primary keratinocytes.
Further studies need to be performed to elucidate whether
hBD-3 gene expression in HaCaT and primary keratinocytes
is regulated in a different manner.
TNF-a and IL-1b induce hBD-2 in primary keratinocytes
as it has been shown in respiratory epithelial cells (Harder
et al, 2000; Tsutsumi-Ishii and Nagaoka, 2003). Given the
fact that the hBD-2 promoter contains two proximal putative
binding sites for NF-kB (Harder et al, 2000; Liu et al, 1998), a
transcription factor known to be activated by proinflamma-
tory stimuli like TNF-a and IL-1b, it is likely that NF-kB might
be involved in the TNF-a- and IL-1b-mediated hBD-2 gene
induction in keratinocytes. Indeed, it has been recently
shown that the TNF-a- and IL-1b-mediated hBD-2 induction
in the lung epithelial cell line A549 requires binding of NF-kB
to a proximal NF-kB binding site in the hBD-2 promoter
(Tsutsumi-Ishii and Nagaoka, 2003).
INF-g effectively induced hBD-3 gene expression in pri-
mary keratinocytes, a finding also reported for HaCaT
keratinocytes (Garcia et al, 2001). It is very likely that a sig-
nal transducer and activator of transcription (STAT) binding
site found in the hBD-3 promoter is involved in the signal
Figure 3
Retinoic acid (RA) inhibits IL-1b-mediated hBD-2 induction in hu-
man primary keratinocytes in a concentration-dependent manner.
Primary keratinocytes were stimulated with (þ ) or without () IL-1b (10
ng per mL) for 16 h. Stimulations were performed either without
addition of 107 M all-trans-RA or with simultaneous addition of the
indicated concentrations of all-trans-RA (107–1011 M) and an
additional pre-incubation for 24 h with all-trans-RA at the indicated
concentrations. Bars represent the relative hBD-2 transcript levels
(analyzed by real-time RT-PCR) normalized to GAPDH transcript levels.
The data represent the mean  SD of triplicate samples.
Figure 4
Retinoic acid (RA) inhibits activation of hBD-2 promoter in human
primary keratinocytes. Primary keratinocytes were transiently trans-
fected with a luciferase gene reporter vector containing hBD-2 pro-
moter as described under ‘‘Material and Methods’’. Twenty-four hours
after transfection cells were stimulated with 10 ng per mL IL-1b for 16 h.
Stimulations were performed either without addition of 107 M all-
trans-RA (RA) or with simultaneous addition of 107 M all-trans-RA
and an additional pre-incubation for 24 h with 107 M all-trans-RA
(þRA). After stimulation cells were harvested and hBD-2 promoter
activity was determined as a ratio between firefly and renilla luciferase
activity. The data represent the mean  SD of triplicate cultures.
Figure5
Retinoic acid (RA) inhibits induction of hBD-2 peptide expression
in human primary keratinocytes. Primary keratinocytes were stimu-
lated with 10 ng per mL IL-1b for 16 hrs. Stimulations were performed
either without addition of 107 M all-trans-RA (RA) or with simulta-
neous addition of 107 M all-trans-RA and an additional pre-incubation
for 24 h with 107 M all-trans-RA (þRA). Thirty micrograms total pro-
tein extracts were subjected to western-blot analysis using antibodies
directed against hBD-2.
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transduction pathway leading to induction of hBD-3 upon
simulation with INF-g (Garcia et al, 2001).
Interestingly, we observed that treatment of keratino-
cytes with all-trans-RA downregulated the TNF-a-, IL-1b-,
INF-g-, PMA-, and P. aeruginosa-mediated induction of
hBD-2, -3, and -4 gene expression. To our knowledge this is
the first report demonstrating the inhibition of antimicrobial
protein expression by RA. In other biological systems, an
opposite effect of RA on antimicrobial proteins has been
reported. It has been demonstrated that in murine embry-
onic stem cells the expression of the antimicrobial protein
lactoferrin is induced by RA (Geng et al, 1998). Furthermore,
it has been shown that expression of the antimicrobial por-
cine cathelicidin PR-39 in bone marrow cells is also induced
by RA (Wu et al, 2000). It would be interesting to investigate
whether the induction of epithelial b-defensins derived from
mice, pigs, or other animals are also inhibited by RA as
shown here for the hBD.
All-trans-RA elicits its biological effects by binding to and
activating the retinoic acid receptors (RAR), which belong to
the steroid/thyroid receptor family (Chambon, 1994). Upon
ligand binding, RAR form heterodimers with the retinoid x
receptors (RXR) and regulate gene expression either by di-
rectly binding to specific cis-acting retinoic acid response
elements (RARE) (Love and Gudas, 1994) or by antagoniz-
ing the AP1 (c-Jun/c-Fos)-mediated gene expression
(Schule et al, 1991; Pfahl, 1993). Interestingly, the promoter
regions of all inducible hBD contain several putative binding
sites for AP-1. Furthermore, it has been shown that AP-1 is
involved in gene induction upon stimulation with proinflam-
matory cytokines (Baud et al, 1999), PMA (Diaz et al, 2000),
Ca2þ (Ng et al, 2000), and bacteria (Hobbie et al, 1997;
Jendrossek et al, 2001). Therefore, one could speculate that
AP-1 may be involved in the TNF-a-, IL-1b-, INF-g-, PMA-,
Ca2þ -, and P. aeruginosa-mediated hBD-2, -3, and -4 gene
induction in primary keratinocytes and that inhibition of AP-
1 may be, in part, responsible for the observed potent in-
hibition of hBD-2, -3, and -4 gene expression by all-trans-
RA. But given the AP-1 binding site consensus sequence of
only six nucleotides and the high occurrence of these sites
in the entire human genome, additional experiments are
needed to investigate the role of AP-1 on the inhibition of
the TNF-a-, IL-1b-, INF-g-, PMA-, Ca2þ -, and P. aerugi-
nosa-mediated hBD-2, -3, and -4 gene induction in primary
keratinocytes.
In summary, we have shown that human keratinocytes
also express hBD-4 and that gene expression of hBD-2, -3,
and -4 is strongly upregulated during Ca2þ -induced differ-
entiation in primary keratinocytes and that all-trans-RA
completely abolished this effect. Furthermore, we have
demonstrated that hBD-2, -3, and -4 genes were differen-
tially induced in primary keratinocytes and that all-trans-RA
is a potent inhibitor of b-defensin induction in keratinocytes
that might downregulate the inducible innate chemical
defense system of human skin. It has been reported
that some patients developed Staphylococcus aureus in-
fection during or shortly after a therapy with RA (Graham
et al, 1986; James and Leyden, 1987). Therefore it would be
interesting to investigate whether skin and other epithelia
are more susceptible to infections during intensive RA
treatment.
Materials and Methods
Cell culture and stimulation Foreskin-derived keratinocytes were
isolated from neonatal foreskins and cultured in keratinocyte
growth medium (KGM, Clonetics, San Diego, CA) in 5% CO2 at
371C as described (Wiedow et al, 1998). Isolation of human
keratinocytes from foreskin was approved by the Institutional
Review Board of the University of Kiel. For stimulation and sub-
sequent RNA or protein isolation, primary keratinocytes were cul-
tured in 6-well tissue culture plates (9.6 cm2 per well, Falcon).
Second passage cells were used at 70%–80% confluence. After
removal of growth medium, the cells were washed twice with
phosphate-buffered saline (PBS) before being cultured in KGM-
Medium (Clonetics) lacking bovine pituitary extract (BPE) for 24 h.
The cells were subsequently stimulated either with 1.7 mM Ca2þ
for the indicated time periods or with 50 ng per mL PMA (Sigma,
Taufkirchen, Germany) or 10 ng per mL TNF-a or IL-1b or INF-g (all
Pepro-Tech Inc., London, UK) or 107 per mL heat-inactivated
(651C, 45 min) P. aeruginosa (clinical isolate) for 16 h. In order to
study the influence of RA on b-defensin gene expression, keratin-
ocytes were stimulated as described above in the presence of
107 M all-trans-RA (Sigma). In some experiments the cells were
pre-incubated with 107 M all-trans-RA for 24 h before the addition
of the indicated stimuli.
Real-time RT-PCR After stimulation, total RNA was isolated and
reversed transcribed using standard reagents (Gibco-BRL, Karls-
ruhe, Germany). The resulting cDNA served as a template in a real-
time PCR reaction in a fluorescence temperature cycler (Light-
Cycler, Roche Diagnostics GMBH, Mannheim, Germany) as previ-
ously described (Harder et al, 2001). This technique continuously
monitors the cycle-by-cycle accumulation of fluorescently labeled
PCR product. Briefly, cDNA corresponding to 10 ng RNA served as
a template in a 10 mL reaction containing 4 mM MgCl2, 0.5 mM of
each primer and 1  LightCycler-FastStart DNA Master SYBR
Green I mix (Roche Diagnostics GMBH). Samples were loaded into
capillary tubes and incubated in the fluorescence thermocycler
(LightCycler) for an initial denaturation at 951C for 10 min followed
by 45 cycles, each cycle consisting of 951C for 15 s, ‘‘touchdown’’
of 11C per cycle from the primer specific start to end annealing
temperature (Table I) for 5 s and 721C for 10 s. At the end of each
run, melting curve profiles were produced by cooling the sample to
651C for 15 s and then heating slowly at 0.201C per s up to 951C
with continuous measurement of fluorescence to confirm amplifi-
cation of specific transcripts. Cycle-to-cycle fluorescence emis-
sion readings were monitored and analyzed using LightCycler
Software (Roche Diagnostics GMBH). The specificity of the ampli-
fication products was further verified by subjecting the amplifica-
tion products to electrophoresis on a 2% agarose gel. The
fragments were visualized by ethidium bromide staining and the
specificity of PCR products was verified by sequencing of repre-
sentative samples. Specific, intron-spanning primers and specific
temperatures were used as shown in Table I. Standard curves were
obtained for each primer set with serial dilutions of cDNA. Ampli-
fication of the housekeeping gene glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) served as a control for equal amounts of
cDNA. Relative b-defensin transcript levels were corrected by nor-
malization based on the GAPDH transcript levels.
Luciferase gene reporter assay To analyze hBD-2 promoter ac-
tivity 2338 bp of the hBD-2 promoter was amplified using the
primers 50-CAGTACAGCAGCAGTGATAG-30 and 50-GGGGAGGA-
CATCAAGCCTT-30. The amplification product was subcloned into
the promoterless pGL3-basic firefly luciferase vector (Promega,
Madison, WI) to generate hBD-2-pGL3 reporter plasmid. Primary
keratinocytes were seeded in 12-well plates (4 cm2 per well,
Falcon) and used for transfection at 60%–80% confluence. Cells
were transfected with 0.5 mg of hBD-2-pGL3 reporter plasmid and
0.025 mg of an internal control renilla luciferase expression plasmid
(phRG-TK, Promega) using 1 mL transfection reagent Fugene6
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(Roche Diagnostics GMBH) according to the manufacturer’s in-
structions. Twenty-four hours after transfection, the cells were pre-
incubated with or without 107 M all-trans-RA for 24 h before the
addition of 10 ng per mL IL-1b for 16 h. After stimulation, cells were
harvested with 500 mL passive lysis buffer (Promega) and firefly
luciferase activity from hBD-2-pGL3 reporter plasmid and renilla
luciferase activity were measured by the Dual Luciferase assay
system (Promega) on a TD-20/20 luminometer (TURNER DESIGN,
CA). Promoter activity was reported as the ratio between firefly and
renilla luciferase activities in each sample.
Western blot For protein isolation primary keratinocytes were
harvested in 60% acetonitrileþ 1% trifluoroacetic acid and lysed
by sonication. After centrifugation (10,000  g, 15 min) supernat-
ants were lyophilized and resupended in 0.01% acetic acid.
Protein extracts (30 mg) were separated onto a 16.5% SDS-
tricine polyacrylamide gel containing 8 M urea (Schagger and von
Jagow, 1987). Proteins were transferred to a Protran-nitrocellulose
membrane (Schleicher & Schuell BioScience, Dassel, Germany),
blocked for 1 h in blocking buffer (5% (wt per vol) non-fat pow-
dered milk in PBSþ 0.05% Tween), then incubated for 18 h at 41C
in 3% (wt per vol) non-fat powdered milk in PBSþ 0.05% Tween
containing 1:25,000 hBD-2 rabbit antiserum (Peptide Institute,
Japan). The membrane was washed with PBSþ 0.05% Tween six
times for 6 min each, then incubated for 1 h in 3% (wt per vol) non-
fat powdered milk in PBSþ 0.05% Tween containing 1:20,000 di-
lution of goat antirabbit IgG HRP conjugate (Dianova, Hamburg,
Germany). After six washes as before, the membrane was incu-
bated for 5 min with chemiluminescent peroxidase substrate
(Sigma, Taufkirchen, Germany) and visualized using a Diana III cooled
CCD-camera imaging system (Raytest, Straubenhardt, Germany).
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